GEODIS announces a project to acquire GANDON Transports to enhance its healthcare offering · GEODIS announces a project to acquire GANDON Transports to enhance its healthcare offering GEODIS has signed an agreement to acquire GANDON Transports, a leading player in the transport of temperature-controlled pharmaceutical products. Delivery: our advice for measuring and improving the customer experience · Delivery: our advice for measuring and improving the customer experience Measure the quality of your customer experience and improve it constantly - it’s fundamental to your business! E-commerce and new consumer demands: how is transport adapting? · E-commerce and new consumer demands: how is transport adapting? The delivery of goods must be increasingly precise and include additional services to better satisfy customers. The challenges of investing in warehouse automation · The challenges of investing in warehouse automation How can you mitigate the risk before taking the leap? Lines of Business · Lines of Business GEODIS is the growth partner of choice for clients world over, owing to our expertise in every aspect of supply chain logistics. Purpose & Core Values · Purpose & Core Values Serving people by delivering their goods all around the world with innovative, sustainable and ethical logistics. How to overcome the challenges facing the pharmaceutical cold chain industry? · How to overcome the challenges facing the pharmaceutical cold chain industry? The purpose of temperature-controlled transport and storage for medicines Expanding your B2C e-commerce business to the European market · Expanding your B2C e-commerce business to the European market As global e-commerce booms, cross-border logistic solutions are more crucial than ever. Recruiting Young Talents · Recruiting Young Talents Want to recruit young talent? Focus on coaching, training and mobility, researchers say. Verticals · Verticals Each sector has unique characteristics and requirements, such as specific transportation modes, specialized equipment, and regulatory compliance. 10 11 12 13 14